These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 1345732)

  • 1. Magnetic resonance imaging in multiple sclerosis: an overview.
    Colosimo M; Amatruda A; Cioffi RP
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):113-23. PubMed ID: 1345732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of MRI in the diagnosis of multiple sclerosis.
    Traboulsee AL; Li DK
    Adv Neurol; 2006; 98():125-46. PubMed ID: 16400831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.
    Smith ME; Stone LA; Albert PS; Frank JA; Martin R; Armstrong M; Maloni H; McFarlin DE; McFarland HF
    Ann Neurol; 1993 May; 33(5):480-9. PubMed ID: 8498825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical usefulness of MRI in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase].
    Nomura M; Suzumura A; Anno H; Miyata E; Koga S; Yamamoto H
    Rinsho Shinkeigaku; 1995 Mar; 35(3):225-30. PubMed ID: 7614741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance imaging of disseminated sclerosis].
    Christiansen AP; Wanscher B; Larsson HB; Henriksen O
    Ugeskr Laeger; 1994 Oct; 156(43):6348-52. PubMed ID: 7810007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis.
    Katz D; Taubenberger JK; Cannella B; McFarlin DE; Raine CS; McFarland HF
    Ann Neurol; 1993 Nov; 34(5):661-9. PubMed ID: 8239560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis].
    Sailer M; Fazekas F; Gass A; Kappos L; Radue EW; Rieckmann P; Toyka K; Wiendl H; Bendszus M
    Rofo; 2008 Nov; 180(11):994-1001. PubMed ID: 18937154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic criteria of multiple sclerosis in neuroimaging].
    Dupel-Pottier C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):949-62. PubMed ID: 11787360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].
    Rüttinger H; Hermes M
    Nervenarzt; 1990 Jun; 61(6):356-60. PubMed ID: 2377261
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intracranial tumor-like lesions in children and young adults with multiple sclerosis].
    Einig M; Higer HP; Mauz M; Ernst JP
    Rofo; 1992 Oct; 157(4):384-9. PubMed ID: 1391842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain metastasis of small cell lung carcinoma: comparison of Gd-DTPA enhanced magnetic resonance imaging and enhanced computerized tomography.
    Nomoto Y; Miyamoto T; Yamaguchi Y
    Jpn J Clin Oncol; 1994 Oct; 24(5):258-62. PubMed ID: 7967105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serial magnetic resonance imaging of acute disseminated encephalomyelitis, including evaluation of the contrast-enhancing effect of lesions by Gd-DTPA].
    Tanaka Y; Matsuo M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jan; 56(1):25-31. PubMed ID: 8857095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major differences in the dynamics of primary and secondary progressive multiple sclerosis.
    Thompson AJ; Kermode AG; Wicks D; MacManus DG; Kendall BE; Kingsley DP; McDonald WI
    Ann Neurol; 1991 Jan; 29(1):53-62. PubMed ID: 1996879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis.
    Wiebe S; Lee DH; Karlik SJ; Hopkins M; Vandervoort MK; Wong CJ; Hewitt L; Rice GP; Ebers GC; Noseworthy JH
    Ann Neurol; 1992 Nov; 32(5):643-50. PubMed ID: 1449244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging advances in multiple sclerosis.
    Bakshi R
    J Neuroimaging; 2005; 15(4 Suppl):5S-9S. PubMed ID: 16385014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B; Laniado M; Saini S
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis].
    Rovira A; Tintoré M; Alvarez-Cermeño JC; Izquierdo G; Prieto JM
    Neurologia; 2010 May; 25(4):248-65. PubMed ID: 20609303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics.
    Leist TP; Marks S
    Neurology; 2010 Jan; 74 Suppl 1():S54-61. PubMed ID: 20038764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.